• Offers advice in Preclinical Development from early research to regulatory submissions, including molecule screening and lead candidate selection.• Contributed to successful IND.• Member of Scientific Advisory Board• Capacity to advise on small company operations and expansion, as well as people and programme management.

• Lead the functional area responsible for TCR Discovery and Preclinical/non-clinical activities, with 3 direct reports and ~25 indirect reports.• Oversee all non-clinical cell biology research activities related to i) identification of T cell receptors as bases for ImmTAX molecules across a variety of disease areas for both wholly-owned and partner programmes, ii) identification of lead drug candidates, and iii) all non-clinical regulatory activities in collaboration with Clinical and Regulatory teams, including delivery of non-clinical documents for submission to health authorities (including two successful IND submissions or equivalent, one ongoing BLA).• Provide regular updates of regulatory and clinical documents following the initiation of first-in-human studies. Involved in clinical development portfolio governance meetings.• Oversee all cell biology process enhancement activities aiming to improve or accelerate the development of drug candidates (e.g. high throughput screening of molecules using automation).• Lead a franchise of several interconnected programmes for efficient and coordinated strategic delivery.• Core member of the Research Portfolio Committee, which governs and prioritises Research portfolio projects across all disease areas.• Core member of the Research Leadership Team, which ensures the effective functioning of Research at the scientific, personnel, and operational perspectives, and defines Research strategy.• Contribute to personal development of associate directors and scientists, through training, mentoring, and coaching.

• Led the functional area related to Preclinical activities/non-clinical activities mentioned above.

• Led a group of six scientists with responsibility for (i) screening bispecific molecules in several oncology programmes, (ii) generating preclinical data for regulatory submissions, (iii) developing new cellular models including 3D models, and (iv) in collaboration with other departments optimizing high throughput screening techniques. • Co-lead for the clinical development of a drug candidate, including the coordination of a matrix team of functional experts, definition of the clinical strategy for the first-in-human and subsequent studies, reporting to senior executive management. • Preclinical functional lead for the clinical development of a drug candidate overseeing data generation and completion of clinical documents for regulatory authorities.• Contributed to the implementation of programme leadership and matrix teams in different parts of the company.• Contributed to company-wide efforts to implement informatics tools for optimal management of the pipeline.• Selected for and participated in Leadership and Management training, and part of a team aiming to develop leadership and self-development workshops for company staff.• Contributed to personal development of scientists, through training, mentoring, and coaching.

• Led a group of six scientists with responsibility for (i) screening bispecific molecules in several oncology programmes, (ii) generating preclinical data for regulatory submissions, (iii) developing new cellular models including 3D models, and (iv) in collaboration with other departments optimizing high throughput screening techniques.• Contributed to the initiation of programme leadership and matrix teams, and acted as a programme leader and preclinical functional lead.

• Led a group of two scientists with responsibility for (i) screening bispecific molecules in several oncology programmes, and (ii) developing new cellular models including 3D models.• Contributed to preclinical data generation for regulatory submission of a drug candidate, contributed to the writing of study reports.

• Contributed and led screening of molecules in collaboration with an industrial partner.• Initiated the development of 3D cellular models.

• Translation (English to French) of technical documentation for scientific companies (e.g. request for information documents).

• Initiated or developed research projects investigating the molecular processes of cancer progression and search for markers of progression or predictive/prognostic markers, including the role of TGFbeta on tumour initiation and progression, cancer signalling, and regulation of cytoskeleton.• Collaborated with physicists and chemists in Polytechnique Montreal within a multidisciplinary team for a new laser-based therapeutic strategy for skin cancer treatment.• Collaborated with another cancer research laboratory for the development of buffers for fast semi-dry transfer of proteins for Western blot.• Wrote one grant application for the Canadian Institutes of Health Research and one grant application for L’Oréal, ten studentships applications, two peer-reviewed first-author research articles, two peer-reviewed first-author review articles, one web review, and one book chapter, participated in the writing of two second-author collaborative research articles.• Managed laboratory administration and budget for 3 years, acted as an onsite representative for Bio-Rad supply centre and managed purchasing for onsite customers for 3 years.• Trained and coached seven undergraduate students.

• Developed a project on the immunogenic properties of the HIV Tat protein, using cell-based assays, biochemistry, and in vivo studies.

• Developed a project on the effects of lovastatin on breast cancer cells, using cell-based assays and biochemistry.• Acted as teaching assistant.

• Developed a project about the effects of retinoic acids in Ewing Sarcoma, including on cytoskeleton and cell migration.

• Contributed to an ongoing project about the regulation of an integrative and conjugative element ICESt1 in Streptococcus thermophiles, developed molecular biology techniques.

• Contributed to an ongoing project about the effects on ozone on poplar growth and metabolism,developed biochemistry techniques (part time).